Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin S Reiners

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|March 19, 2014
Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell PlasticityKatrin S Reiners, Juliane Dassler, Christoph Coch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphomaKatrin S Reiners, Axel Gossmann, Elke Pogge von Strandmann, et al.
Biological Chemistry|June 22, 2013
Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitroMaike Sauer, Katrin S Reiners, Hinrich P Hansen, et al.
Frontiers in Genetics|February 21, 2015
DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapiesOlga M Shatnyeva, Hinrich P Hansen, Katrin S Reiners, et al.
Biomedicines|September 27, 2025
Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC PatientsDian Jamel Salih, Katrin S Reiners, Domenico Loizzi, et al.
Biological Chemistry|May 26, 2012
A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cellsVijaya Lakshmi Simhadri, Hinrich P Hansen, Venkateswara R Simhadri, et al.
American Journal of Hematology|December 11, 2012
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphomaMaike Sauer, Annette Plütschow, Ron D Jachimowicz, et al.
Immunology|May 19, 2004
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigenKatrin S Reiners, Hinrich P Hansen, Anne Krüssmann, et al.
Plos One|November 27, 2013
The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell linesJan M Klein, Alexander Henke, Maike Sauer, et al.
Oncoimmunology|September 22, 2017
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulationMaulik Vyas, Silke Reinartz, Nathalie Hoffmann, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|March 19, 2014
Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell PlasticityKatrin S Reiners, Juliane Dassler, Christoph Coch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphomaKatrin S Reiners, Axel Gossmann, Elke Pogge von Strandmann, et al.
Biological Chemistry|June 22, 2013
Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitroMaike Sauer, Katrin S Reiners, Hinrich P Hansen, et al.
Frontiers in Genetics|February 21, 2015
DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapiesOlga M Shatnyeva, Hinrich P Hansen, Katrin S Reiners, et al.
Biomedicines|September 27, 2025
Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC PatientsDian Jamel Salih, Katrin S Reiners, Domenico Loizzi, et al.
Biological Chemistry|May 26, 2012
A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cellsVijaya Lakshmi Simhadri, Hinrich P Hansen, Venkateswara R Simhadri, et al.
American Journal of Hematology|December 11, 2012
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphomaMaike Sauer, Annette Plütschow, Ron D Jachimowicz, et al.
Immunology|May 19, 2004
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigenKatrin S Reiners, Hinrich P Hansen, Anne Krüssmann, et al.
Plos One|November 27, 2013
The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell linesJan M Klein, Alexander Henke, Maike Sauer, et al.
Oncoimmunology|September 22, 2017
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulationMaulik Vyas, Silke Reinartz, Nathalie Hoffmann, et al.
Pageof 4